Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Journal of hematotherapy

Showing results (131-140 of 369) with videos related to

Pageof 37
Sort By:
Journal of Hematotherapy|January 27, 1999
Ex vivo expansion and differentiation of unselected peripheral blood progenitor cells in serum-free mediaR L Paquette, E Gonzales, R Yoshimura, et al.
Journal of Hematotherapy|January 27, 1999
Minimization of CD34+ cell enumeration variability using the ProCOUNT standardized methodologyI McNiece, B Kern, K Zilm, et al.
Journal of Hematotherapy|October 1, 1995
Bispecific monoclonal antibodies for intravenous treatment of carcinoma patients: immunobiologic aspectsB J Kroesen, R A Janssen, J Buter, et al.
Journal of Hematotherapy|October 1, 1995
Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neuF H Valone, P A Kaufman, P M Guyre, et al.
Journal of Hematotherapy|November 26, 1998
Fluorescence in situ hybridization for the BCR/ABL rearrangement is dependent on the percentage of nonlymphocytic cells in peripheral blood stem cell harvestsM Bornhäuser, B Mohr, U Ehrenlechner, et al.
Journal of Hematotherapy|November 26, 1998
CD34+ cell selection from frozen cord blood products using the Isolex 300i and CliniMACS CD34 selection devicesI K McNiece, G B Stoney, B P Kern, et al.
Journal of Hematotherapy|December 1, 1996
Tumor cell contamination of bone marrow harvest products: clinical consequences in a cohort of advanced-stage breast cancer patients undergoing high-dose chemotherapyB E Brockstein, A A Ross, T J Moss, et al.
Journal of Hematotherapy|December 1, 1996
Standardization of the CFU-GM assay using hematopoietic growth factorsI D Lewis, T Rawling, P G Dyson, et al.
Journal of Hematotherapy|December 1, 1996
The effects of Flk-2/flt3 ligand as compared with c-kit ligand on short-term and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood, bone marrow, and mobilized peripheral bloodF Shapiro, B Pytowski, S Rafii, et al.
Journal of Hematotherapy|December 1, 1996
Ex vivo expansion of hematopoietic progenitors from CD34+ cells selected from leukapheresis products of lymphoma and myeloma patients: feasibility and enhancement by fibronectinB Mahé, D Pineau, N Robillard, et al.
Pageof 37

Showing results (131-140 of 369) with videos related to

Sort By:
Pageof 37
Journal of Hematotherapy|January 27, 1999
Ex vivo expansion and differentiation of unselected peripheral blood progenitor cells in serum-free mediaR L Paquette, E Gonzales, R Yoshimura, et al.
Journal of Hematotherapy|January 27, 1999
Minimization of CD34+ cell enumeration variability using the ProCOUNT standardized methodologyI McNiece, B Kern, K Zilm, et al.
Journal of Hematotherapy|October 1, 1995
Bispecific monoclonal antibodies for intravenous treatment of carcinoma patients: immunobiologic aspectsB J Kroesen, R A Janssen, J Buter, et al.
Journal of Hematotherapy|October 1, 1995
Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neuF H Valone, P A Kaufman, P M Guyre, et al.
Journal of Hematotherapy|November 26, 1998
Fluorescence in situ hybridization for the BCR/ABL rearrangement is dependent on the percentage of nonlymphocytic cells in peripheral blood stem cell harvestsM Bornhäuser, B Mohr, U Ehrenlechner, et al.
Journal of Hematotherapy|November 26, 1998
CD34+ cell selection from frozen cord blood products using the Isolex 300i and CliniMACS CD34 selection devicesI K McNiece, G B Stoney, B P Kern, et al.
Journal of Hematotherapy|December 1, 1996
Tumor cell contamination of bone marrow harvest products: clinical consequences in a cohort of advanced-stage breast cancer patients undergoing high-dose chemotherapyB E Brockstein, A A Ross, T J Moss, et al.
Journal of Hematotherapy|December 1, 1996
Standardization of the CFU-GM assay using hematopoietic growth factorsI D Lewis, T Rawling, P G Dyson, et al.
Journal of Hematotherapy|December 1, 1996
The effects of Flk-2/flt3 ligand as compared with c-kit ligand on short-term and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood, bone marrow, and mobilized peripheral bloodF Shapiro, B Pytowski, S Rafii, et al.
Journal of Hematotherapy|December 1, 1996
Ex vivo expansion of hematopoietic progenitors from CD34+ cells selected from leukapheresis products of lymphoma and myeloma patients: feasibility and enhancement by fibronectinB Mahé, D Pineau, N Robillard, et al.
Pageof 37